| Coventry Group Limited (CYG) ORDINARY FULLY PAID |
Industrials |
$54 |
CYG FY25 results investor presentation
|
29 Aug 2025 4:06PM |
$0.715 |
$0.390 |
fallen by
45.45%
|
|
CYG - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue decreased by 1.7% to A$364.6 million.
- EBITDA fell by 40.9% to A$12.3 million.
- Impact of new ERP system implementation and economic downturn.
- Strategic restructuring with new CEO and CFO.
- Focus on cost reduction and sales growth.
- FY26 EBITDA guidance of over A$20 million.
- Continued challenges in the construction industry affecting performance.
- Capital allocation reset to restore shareholder value.
- Prioritizing cash generation and debt reduction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Macarthur Minerals Limited (MIO) ORDINARY FULLY PAID |
Materials |
$9 |
Results of 2025 Annual General Meeting
|
29 Aug 2025 4:06PM |
$0.023 |
$0.024 |
risen by
4.35%
|
|
| Senetas Corporation Limited (SEN) ORDINARY FULLY PAID |
Information Technology |
$42 |
Return of Capital - SEN
|
29 Aug 2025 4:06PM |
$0.019 |
$2.550 |
risen by
13,321.05%
|
|
| Coventry Group Limited (CYG) ORDINARY FULLY PAID |
Industrials |
$54 |
CYG FY25 results media announcement
|
29 Aug 2025 4:06PM |
$0.715 |
$0.390 |
fallen by
45.45%
|
|
CYG - Price-sensitive ASX Announcement
Full Release
Key Points
- Group Sales for FY25 down 1.7% to $364.6 million.
- Underlying EBITDA down 40.9% to $12.3 million.
- Statutory net loss of $29.6 million due to ERP costs and asset impairment.
- Dividends suspended to focus on debt reduction and growth.
- New ERP system implementation impacted FY25 financial performance.
- Refreshed executive team focusing on 'back to basics' strategy.
- FY26 earnings guidance over $20 million EBITDA.
- Board confident in market opportunities, no significant structural issues.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Senetas Corporation Limited (SEN) ORDINARY FULLY PAID |
Information Technology |
$42 |
Consolidation/Split - SEN
|
29 Aug 2025 4:05PM |
$0.019 |
$2.550 |
risen by
13,321.05%
|
|
| Coventry Group Limited (CYG) ORDINARY FULLY PAID |
Industrials |
$54 |
CYG FY25 Annual Report with 4E
|
29 Aug 2025 4:05PM |
$0.715 |
$0.390 |
fallen by
45.45%
|
|
CYG - Price-sensitive ASX Announcement
Full Release
Key Points
- Coventry Group Ltd reported a total income tax benefit of $2,816,000 for FY25, after a loss of $32,371,000 before tax.
- The Group's earnings per share for FY25 was a loss of 24.9 cents compared to a profit of 0.7 cents in FY24.
- Total liabilities from financing activities increased to $140,910,000 by the end of the financial year.
- The Group carried forward tax losses amounting to $9,732,000 as deferred tax assets.
- Cash and cash equivalents decreased from $7,727,000 to $3,335,000 over the year.
- Directors' remuneration was reported at $1,130,586 for FY25.
- The company's shares are listed on the ASX under the code CYG.
- An on-market buy-back of a maximum of 11,679,081 ordinary shares was announced for the period from September 2024 to September 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coventry Group Limited (CYG) ORDINARY FULLY PAID |
Industrials |
$54 |
CYG FY25 Annual Report with 4E
|
29 Aug 2025 4:05PM |
$0.715 |
$0.390 |
fallen by
45.45%
|
|
CYG - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $29.6 million for FY25
- Revenue decreased by 1.7% to $364.6 million
- Underlying EBITDA fell 40.9% to $12.3 million
- Challenges included softer market conditions and ERP implementation
- Dividend suspension to focus on debt reduction and growth
- Commitment to safety and integrity
- Financial statements comply with regulatory standards
- Annual general meeting set for 21 November 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SiteMinder Limited (SDR) ORDINARY FULLY PAID |
Information Technology |
$883 |
Application for quotation of securities - SDR
|
29 Aug 2025 4:03PM |
$6.910 |
$3.120 |
fallen by
54.85%
|
|
| Ansell Limited (ANN) ORDINARY FULLY PAID |
Health Care |
$3,732 |
Notification of cessation of securities - ANN
|
29 Aug 2025 4:03PM |
$33.940 |
$26.420 |
fallen by
22.16%
|
|
| Cardiex Limited (CDX) ORDINARY FULLY PAID |
Health Care |
$20 |
Unmarketable Parcels of Shares (Buy-Back)
|
29 Aug 2025 4:01PM |
$0.031 |
$0.036 |
risen by
16.13%
|
|
| Inghams Group Limited (ING) ORDINARY FULLY PAID |
Consumer Staple |
$630 |
Ceasing to be a substantial holder
|
29 Aug 2025 4:00PM |
$2.720 |
$1.695 |
fallen by
37.68%
|
|
| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$12 |
FY25 Appendix 4G and Corporate Governance Statement
|
29 Aug 2025 4:00PM |
$0.470 |
$0.425 |
fallen by
9.57%
|
|
| 8Common Ltd (8CO) ORDINARY FULLY PAID |
Information Technology |
$4 |
2025 Corporate Governance Statement
|
29 Aug 2025 3:59PM |
$0.026 |
$0.020 |
fallen by
23.08%
|
|
| Mustera Property Group Limited (MPX) ORDINARY FULLY PAID |
Real Estate |
$19 |
Appendix 4G and 2025 Corporate Governance Statement
|
29 Aug 2025 3:58PM |
$0.210 |
$0.130 |
fallen by
38.10%
|
|
| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$12 |
FY25 Appendix 4E and Annual Report
|
29 Aug 2025 3:56PM |
$0.470 |
$0.425 |
fallen by
9.57%
|
|
CMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax of $3.84 million for the year ended 30 June 2025.
- Accumulated losses totaled $46.59 million.
- Total equity amounted to $1.84 million.
- Revenue primarily from royalty income in the USA.
- Significant expenses in research and development and corporate operations.
- Share issuance and share-based payments were key financial activities.
- Executive remuneration and shareholder information detailed.
- Focus on biotechnology innovations and strategic financial management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$12 |
FY25 Appendix 4E and Annual Report
|
29 Aug 2025 3:56PM |
$0.470 |
$0.425 |
fallen by
9.57%
|
|
CMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Cambium Bio Limited reported a revenue of $670,000 for the year ending 30 June 2025, a 419% increase from the previous year.
- The company recorded a net loss of $3.844 million, a 70% increase in loss compared to the previous year.
- No dividends were paid or proposed for the year.
- Audited by Stantons International Audit and Consulting Pty Ltd.
- The company announced a fully-subscribed A$2.12 million placement to fund the Phase 3 program.
- Key management personnel remuneration included both fixed salaries and a short-term incentive program.
- Total assets decreased from $4.47 million in 2024 to $1.76 million in 2025.
- Shareholder equity fell from $2.82 million to $1.16 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 8Common Ltd (8CO) ORDINARY FULLY PAID |
Information Technology |
$4 |
Appendix 4E and Annual Report to shareholders
|
29 Aug 2025 3:55PM |
$0.026 |
$0.020 |
fallen by
23.08%
|
|
8CO - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for FY25 was $7.3 million, down 11% from FY24.
- SaaS revenue increased to $5.1 million, up 14% from FY24.
- Gross margin increased to 76.5% in Q4 FY25 from 58.4% in Q1.
- Net loss after tax was reduced to $794,000 from $2.5 million in FY24.
- Embedded AI across operations to enhance product development and business efficiency.
- Expanded flagship product Expense8 with new client acquisitions.
- Business development momentum slowed pre-Federal Election but resumed post-election.
- Total contract renewals valued at over $4 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 8Common Ltd (8CO) ORDINARY FULLY PAID |
Information Technology |
$4 |
Appendix 4E and Annual Report to shareholders
|
29 Aug 2025 3:55PM |
$0.026 |
$0.020 |
fallen by
23.08%
|
|
8CO - Price-sensitive ASX Announcement
Full Release
Key Points
- 8Common Limited's flagship product, Expense8, continues to be a leading solution for Travel and Expense Management Software.
- The company reported a 194% improvement in EBITDA, with a $326k profit in the second half of FY25.
- Total revenue for FY25 was $7.3 million, a decrease of 11% from FY24.
- Gross margin expanded to 76.5% in Q4 FY25, up from 58.4% in Q1.
- The Federal Government is a key growth driver, with 51,000 active users and 17,000 more onboarding.
- Contracts and new clients include significant organizations like the National Anti-Corruption Commission and the Australian Institute of Maritime Science.
- CardHero solution has become operationally cashflow positive, contributing $466k in revenue.
- Net loss after tax was reduced to $793,946 from $2,548,338 in FY24.
- The number of users increased by 12.8%, with a rise in SaaS and transaction revenue by 15%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rent.com.au Limited (RNT) ORDINARY FULLY PAID |
Communication Services |
$71 |
Notification of cessation of securities - RNT
|
29 Aug 2025 3:54PM |
$0.037 |
$0.061 |
risen by
64.86%
|
|
| Senetas Corporation Limited (SEN) ORDINARY FULLY PAID |
Information Technology |
$42 |
FY2025 Investor Presentation of Results
|
29 Aug 2025 3:54PM |
$0.019 |
$2.550 |
risen by
13,321.05%
|
|
SEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Senetas Corporation reported an underlying net profit of $1.5 million from continuing operations for FY2025.
- The total net profit was significantly boosted to $27.8 million due to the sale of the Votiro business.
- Revenue from continuing operations was $19.3 million, lower than FY2024's $21.6 million.
- The company maintained a strong gross margin of 87% despite reduced sales.
- Senetas ended FY2025 with $11.6 million in cash and no debt.
- The company has proposed a capital reduction and share consolidation at the 2025 AGM.
- There's an indirect investment in Menlo Security Inc. worth over $17.5 million.
- Senetas is focusing on expanding markets and enhancing product capabilities, including post-quantum encryption.
- The outlook for FY2026 is positive with a strong sales pipeline and opportunities in key growth markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Senetas Corporation Limited (SEN) ORDINARY FULLY PAID |
Information Technology |
$42 |
FY2025 Investor Presentation of Results
|
29 Aug 2025 3:54PM |
$0.019 |
$2.550 |
risen by
13,321.05%
|
|
SEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Senetas Corporation Limited reported an underlying net profit of $1.5 million from continuing operations for FY2025.
- The total reported net profit was $27.8 million, largely due to the sale of the Votiro business.
- Senetas operating revenue fell in FY2025, influenced by tighter customer budgets and management changes at a global distribution partner.
- Gross margins improved by 3 percentage points due to a better product mix.
- Senetas finished FY2025 with $11.6 million in cash and no debt.
- Capital management proposals include a $2 million capital return to shareholders and a 100:1 share consolidation.
- The Votiro sale is expected to streamline operations and enhance Senetas's focus on core network encryption business.
- Senetas is focusing on expanding its market and product offerings, including post-quantum and sovereign encryption capabilities.
- Senetas enters FY2026 with its largest ever sales pipeline and positive outlook for revenue growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$262 |
Cleansing Notice
|
29 Aug 2025 3:54PM |
$0.645 |
$0.650 |
risen by
0.78%
|
|
| Firebrick Pharma Limited (FRE) ORDINARY FULLY PAID |
Health Care |
$15 |
Change in substantial holding - Peter Molloy
|
29 Aug 2025 3:52PM |
$0.075 |
$0.052 |
fallen by
30.67%
|
|
| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$262 |
Application for quotation of securities - AUE
|
29 Aug 2025 3:52PM |
$0.645 |
$0.650 |
risen by
0.78%
|
|
| Firebrick Pharma Limited (FRE) ORDINARY FULLY PAID |
Health Care |
$15 |
Change in substantial holding - Stephen Goodall
|
29 Aug 2025 3:52PM |
$0.075 |
$0.052 |
fallen by
30.67%
|
|
Call 1300 880 160
Start a chat
Schedule a call
